Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Role of ferroptosis and immune infiltration in intervertebral disc degeneration: novel insights from bioinformatics analyses. | Front Cell Dev Biol | 2023 | 37736497 | PubTator, text mining | PubMed |
| Advanced Age in Humans and Mouse Models of Glioblastoma Show Decreased Survival from Extratumoral Influence. | Clin Cancer Res | 2023 | 37725593 | PubTator, text mining | PubMed |
| Single-cell transcriptome analysis uncovers underlying mechanisms of acute liver injury induced by tripterygium glycosides tablet in mice. | J Pharm Anal | 2023 | 37719192 | PubTator, text mining | PubMed |
| MAIT cells confer resistance to Lenvatinib plus anti-PD1 antibodies in hepatocellular carcinoma through TNF-TNFRSF1B pathway. | Clin Immunol | 2023 | 37717672 | PubTator, text mining | PubMed |
| The potential use and experimental validation of genomic instability-related lncRNA in pancreatic carcinoma. | Medicine (Baltimore) | 2023 | 37713870 | PubTator, text mining | PubMed |
| Lung tumor-infiltrating Treg have divergent transcriptional profiles and function linked to checkpoint blockade response. | Sci Immunol | 2023 | 37713507 | PubTator, text mining | PubMed |
| Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer. | Mol Ther Oncolytics | 2023 | 37701851 | PubTator, text mining | PubMed |
| CT radiomics for noninvasively predicting NQO1 expression levels in hepatocellular carcinoma. | PLoS One | 2023 | 37695786 | PubTator, text mining | PubMed |
| Dynamic Changes in miRNA Expression during the Generation of Expanded and Activated NK Cells. | Int J Mol Sci | 2023 | 37686362 | PubTator, text mining | PubMed |
| CAR-NK Cells Generated with mRNA-LNPs Kill Tumor Target Cells In Vitro and In Vivo. | Int J Mol Sci | 2023 | 37686170 | PubTator, text mining | PubMed |
| SMAD Proteins in TGF-β Signalling Pathway in Cancer: Regulatory Mechanisms and Clinical Applications. | Diagnostics (Basel) | 2023 | 37685308 | PubTator, text mining | PubMed |
| Exploration of Key Immune-Related Transcriptomes Associated with Doxorubicin-Induced Cardiotoxicity in Patients with Breast Cancer. | Cardiovasc Toxicol | 2023 | 37684436 | PubTator, text mining | PubMed |
| Dendritic Cell Vaccines: A Shift from Conventional Approach to New Generations. | Cells | 2023 | 37681880 | PubTator, text mining | PubMed |
| Targeting microbial quorum sensing: the next frontier to hinder bacterial driven gastrointestinal infections. | Gut Microbes | 2023 | 37680117 | PubTator, text mining | PubMed |
| Memory T Cells in the Immunoprevention of Cancer: A Switch from Therapeutic to Prophylactic Approaches. | J Immunol | 2023 | 37669503 | PubTator, text mining | PubMed |
| Agonism of 4-1BB for immune therapy: a perspective on possibilities and complications. | Front Immunol | 2023 | 37662949 | PubTator, text mining | PubMed |
| The benefits of clustering in TNF receptor superfamily signaling. | Front Immunol | 2023 | 37662920 | PubTator, text mining | PubMed |
| Unraveling dynamic interactions between tumor-associated macrophages and consensus molecular subtypes in colorectal cancer: An integrative analysis of single-cell and bulk RNA transcriptome. | Heliyon | 2023 | 37662758 | PubTator, text mining | PubMed |
| A fatty acid-rich fraction of an endolichenic fungus Phoma sp. suppresses immune checkpoint markers via AhR/ARNT and ESR1. | Heliyon | 2023 | 37662726 | PubTator, text mining | PubMed |
| Immune checkpoints and cancer immunotherapies: insights into newly potential receptors and ligands. | Ther Adv Vaccines Immunother | 2023 | 37662491 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=17